- Title should be brief and clearly state content.
- Presenting author must list name first.
- List name and status only — e.g., M3, MD, DO, for each author.
- A faculty co-author is required.
The abstract should be organized as follows:
- Purpose of study (one sentence if possible)
- Simple statement of methods
- Summary of results (adequate to support conclusions)
- Statement of conclusions (Do not use phrases such as “The results will be discussed.”)
- Recommended length: 500 words max
The above format may be modified, as appropriate, for Clinical Vignette submissions or for Research submissions diverging from the standard research methods.
No diagrams or tables in the abstract. No references in the abstract.
Write for clarity and directness. Avoid the use of medical jargon or empty stock phrases. Keep in mind that grammar will be taken into consideration. Please proofread your abstract carefully.
Abbreviations, Symbols and Nomenclature
Usage should conform as closely as possible to that recommended in CBE Style Manual (6th edition, 1994), published by the Council of Science Editors. Nonstandard abbreviations must be kept to a minimum, and must be explained when used.
Generic names of drugs are preferred: a proprietary name may be given only with the first use of the generic name.
Units of measurement should be metric (SI), including those for height of length, mass (weight), and body temperature. Measurements: for substances of known, pure composition, millimoles/milliliter or millimoles/liter; for mixtures of substances where exact composition is not known, grams/liter.